本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Summit Therapeutics PLC

18.42
+0.87004.96%
盤前18.19-0.2304-1.25%06:14 EDT
成交量:706.65萬
成交額:1.31億
市值:146.95億
市盈率:-16.48
高:18.83
開:18.07
低:17.97
收:17.55
52周最高:29.23
52周最低:12.07
股本:7.98億
流通股本:1.52億
量比:1.28
換手率:4.64%
股息:- -
股息率:- -
每股收益(TTM):-1.1177
每股收益(LYR):-1.4439
淨資產收益率:-192.50%
總資產收益率:-101.61%
市淨率:23.33
市盈率(LYR):-12.76

資料載入中...

2019/10/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

SEC問詢函

[Cover]Correspondence
2019/06/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露報告

General statement of acquisition of beneficial ownership
2019/01/18

非美公司披露報告

Notice of Exempt Offering of Securities, item 06b
2019/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/22

非美公司披露報告

2018/10/09

非美公司披露報告